Noliterax (Indapamide, Perindopril Arginine)

Indapamide and Perindopril arginine, the active ingredients in Noliterax, are a diuretic and an ACE inhibitor presented as an oral tablet for oral use. They treat hypertension by lowering blood pressure in adult patients. GNH USA supplies Noliterax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noliterax, a combination antihypertensive, is used to manage elevated blood pressure.

Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. Essential hypertension: provides additive blood‑pressure‑lowering effect through diuresis and vasodilation. High‑risk cardiovascular patients: helps achieve target blood pressure when monotherapy is insufficient.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Headache or mild fatigue. - Increased urinary frequency or mild electrolyte imbalance.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Angioedema, including facial or airway swelling. - Hyperkalemia or significant renal function decline. - Pancreatitis or severe allergic reactions. - Blood dyscrasias such as agranulocytosis.

Before initiating therapy, consider the following precautions. - Monitor blood pressure: adjust therapy if target levels are not achieved. - Assess renal function: avoid or adjust dose in severe renal impairment. - Check electrolytes: watch for potassium and sodium disturbances. - Use caution in diabetes: monitor glucose as diuretic may affect control. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

When prescribing Noliterax, be aware of potential drug interactions.

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients may increase risk of renal impairment. - Co‑administration with potassium‑sparing diuretics or supplements can cause dangerous hyperkalemia. - NSAIDs combined with ACE inhibitors may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium levels may rise when taken with thiazide‑like diuretics; monitor serum lithium. - Other antihypertensives can produce additive blood‑pressure lowering; adjust doses accordingly. - Corticosteroids may increase potassium loss; monitor electrolytes. - Digoxin efficacy can be altered by electrolyte shifts; observe cardiac status.